aBSTRACT author Index Eastman, PS 361, 1748 Easton, D 586 Eberhard, BA 2014, 2015, 2047, 2294, 2454, 2624 Ebihara, S 1351 Ebina, K 1571 Ebisawa, M 376 Eckel, RH 100 Eckstein, F 722, 827 Edberg, JC 634, 642, 995, 2311, 2476 Edden, R 970 Edelmann, E 327 Eder, L 524, 525, 537, 544, 1334, 1353, 1868, 2275, 2486E, 2486C Edgar, M 833, 1630 Edison, JD 89 Edmundowicz, D 787, 1446 Edwards, C 601, 605 Edwards, JC 1735, 2225, 2521 Edworthy, SM 1862 Efes, I 480 Effelsberg, NM 814, 2374, 2600 Efthimiou, PV 1190 Egelston, C 734, 1008 Egerer, K 839, 1697, 1745 Eggebeen, AT 710, 2055 Egger, P 1712 Eguchi, K 318, 1218, 1220 Egurbide, M 1405, 1492 Ehrenstein, BP 178 Ehrlich-Jones, LS 1558, 2120 Eicher, JL 1670 Eickenberg, S 1769 Eijsbouts, AM 2407 Eilat, D 2550 Eimon, A 494 Einarsson, JT 432 Einstadter, D 870 Eisfelder, M 532 Eisner, E 1066 Eissa, A 1331 Eitzman, DT 2547 Ejbjerg, BJ 946, 1258 Ekholm, L 59 Eklund, A 2176, 2179 Ekman, EF 828 Eksioglu-Demiralp, E 2391 El Gaafary, M 808, 1690 El Mansouri, FE 80 El Miedany, YM 808, 1690 El-Gabalawy, H 1204 El-Gabalawy, HS 152, 347, 362, 765, 768, 2139, 2163, 2573 El-hallak, M 757 Elashoff, D 254, 593 Elder, JT 1332 Elders, LM 73 Eldridge, H 129 Elegbe, A 1238, 2209, 2231, 2232 Elewaut, D 430, 1356, 1927, 2149 Elhai, M 268, 1456, 1718 Elias, M 1868 Elkayam, JG 886, 2506 Elkayam, O 934, 1002, 1300, 1944 Elkon, KB 559, 656, 997, 1762, 2548 Ellingsen, T 394, 1258 Ellsworth, JE 1633 Eloranta, M 1428, 2478, 2496 Elson, G 63, 977 Elvin, K 1441 Emery, P 126, 200, 429, 463, 667, 704, 705, 779, 944, 1210, 1233, 1245, 1253, 1285, 1612, 1643, 1698, 1699, 1702, 1734, 2144, 2189, 2199, 2208, 2214, 2232, 2236, 2252, 2465, 2486D, 2486F Emmerich, J 859 Emmungil, H 1525 Emrence, Z 166 Encinas, J 202 Endo, H 382, 1127, 1478, 1811, 2565 Endres, J 2334, 2572 Eng, H 135, 393, 2143, 2150, 2516 Engel, R 1823 Engelbrecht, JM 1023 Engelke, K 1611, 1615 Enger, C 433 Engin, A 168, 1947 Englbrecht, M 548, 964, 1208, 1611, 1615, 2527 Engleberg, NC 1003 Englert, J 470 Englund, M 1073, 2509, 2515 Engström, A 2513 Engström, M 2176 Ennis, H 1450, 1467 Enocsson, H 1421 Equinda, M 2518 Era, C 1956 ERAHSE Team 1576 Erar, A 115 Erausquin, C 2268 Ercilla, G 2138 Erdem, H 1886, 2385 Erdes, S 517 Erdozain, J 1405 Erer, B 1328 Ergun, T 2387 Erickson, A 2140, 2152 Erickson, AR 1174 Erickson, EA 1796 Eriksson, C 1156 Eriksson, J 459, 1206, 1884, 2240, 2515, 2523 Eriksson, KG 2480 Erkan, D 7, 726, 727, 867, 1390, 1408, 1666, 2308, 2411 Erman, F 1142, 2081 Ernestam, S 436, 459, 2229, 2513 Ernet, C 1611 Ershova, O 2201 Ertan, S 2305 Esber, A 1691 Escalante, A 111, 1164, 2142 Escher, M 2072 Escorpizo, R 679 Escriou, V 1007 Esdaile, J 804, 1846 Esen, F 923 Esmaeilzadeh, S 930, 1292 Espada, G 612, 2009, 2454, 2621 Esparza-Lopez, J 854 Espericueta-Arriola, G 5 Espígol, G 1518, 1523 Espinosa-Cuervo, G 8 Espinoza, LR 1313, 1949, 2110, 2126 Espitia, O 1510 ESPOIR Scientific Committee 353 Essioux, L 399 Esteller, M 366 Esteva-Spinetti, MH 783 Estrada, P 1524 Estrada-Y-Martin, RM 1452 Etchepare, A 1401 Etchepare, F 180 Etchepare, P 1401 Eto, H 1410 Etzyoni, R 560 Eudy, A 1392, 1857, 1858 Euller-Ziegler, LE 2234 EUSTAR coauthors 692 EUSTAR Rituximab Group 702 EUVAS Investigators 2369 Evans, B 1097, 1105 Evans, DM 153 Evans, E 1757 Evans, G 2015, 2047 Evans, J 83 Evans, RR 1013, 1014, 1015, 1023, 1024 Evans-Raoul, K 1397 Evelyn, B 1000 Everett, C 2070 Everett, S 1666 Ewing, S 1110 Exarchou, A 1071 Exer, P 527 Eyal, R 98 Eyre, S 1677 Ezatollahpour, S 2275 F Fabbriciani, G 1120 Faezi, T 2386 Fagerhol, M 1052 Fagerli, KM 531, 533, 2532 Faham, M 1339 Fahmi, H 67, 80 Fain, O 608 Fain, O 728, 858, 1500, 2035 Falcini, F 283, 1533 Falcione, M 703 Falen, SW 206 Fall, N 1685, 1687 Fallon, N 737 Falzer, P 107, 907 Fan, H 594, 1924 Fan, M 2552 Fan, P 1132 Fan, W 1922 Fang, F 1819 Fang, H 3, 4, 583, 585, 596, 598, 603, 606, 607, 613, 619, 622, 628, 786, 1375, 1383, 1384, 1392, 1656, 1708, 1712, 1853, 1903, 1919, 1920, 2443, 2471 Fang, L 2084 Fang, M 1917 Fang, Y 1710 Fanget, B 2470 Fangradt, M 28, 373, 1005 Fanucci, F 471 Faraone, S 2599 Farber, JL 1461 Fardellone, P 132, 315, 1932 Fardipour, P 2630 Farewell, V 601, 605 Farge, D 673 Farnarier, C 1816 Farnetti, E 2390 Farrell, J 2492 Fasth, A 822 Fathman, CG 54, 2571 Fauchais, A 488 Faulkner, R 2013 Faulkner, RD 1017, 2581 Faustino, A 1792 Fautrel, B 132, 230, 317, 353 Faye, A 2021 Fayyad, R 502, 1293 Fazio, S 2280 Fearon, C 1336 Fearon, U 41, 47, 391, 732, 1176, 1336, 1672, 1829 Fedele, AL 1746, 2343 350 2011 <strong>Program</strong> <strong>Book</strong>
Federici, L 1500 Federici, S 2452 Fedorova, T 1093 Fedorova, T 2569 Feehan, LM 965 Feghali-Bostwick, CA 308, 671, 1490, 1826, 2315, 2537 Fehringer, E 1179, 2112 Feissinger, JN 1500 Feist, E 839, 1096, 1244, 1644, 1745 Feld, J 1868 Feldman, BM 240, 863, 2019, 2027, 2034, 2481 Feldman, CH 1667, 2441 Feldman, D 1914, 1915 Feldman, DE 1546 Feldstein, AC 1106 Felekos, I 1163 Félix, J 1317 Felsenberg, D 1104 Felson, DT 742, 744, 802, 960, 1073, 1076, 1089, 1541, 1616, 1624, 1627, 1628, 1724, 1986, 1989, 1991, 1993, 1995, 2005, 2557, 2560 Feng, D 1428, 2478 Feng, M 1128 Feng, M 2567 Feng, X 644, 2473 Ferbert, SM 1577, 1900, 2408, 2409, 2564 Ferdousi, T 330, 441, 2239 Ferguson, PJ 299 Feria, M 30 Ferland, DS 325, 338, 339, 736, 1198, 1889, 2141, 2457 Ferlet, JF 180 Ferlin, W 63, 977 Fernandes, A 141, 1848, 1861, 1864 Fernandes, AJ 1209 Fernandez, I 823 Fernandez, P 2323 Fernández Rueda, J 2062 Fernández-Castro, M 1492 Fernandez-Cid, JC 1045 Fernández-Costa, C 2554 Fernandez-Gutierrez, B 383, 1084 Fernandez-Llaca, H 81, 1968 Fernández-López, C 2420, 2554 Fernandez-Mazarambroz, RJ 878, 885 Fernández-Moreno, M 2420 Fernandez-Nebro, A 1113 Fernández-Ortiz, AM 319, 1173 Fernandez-Perez, ER 687 Fernández-Puente, P 2554 Ferner, E 817 Ferraccioli, G 270, 703, 1201, 1469, 1529, 1673, 1746, 2214, 2343 Ferrand, C 1738 Ferrandiz, MA 2622 Ferrari, C 942, 2401 Ferrari, M 1274 Ferraz-Amaro, I 1166, 2115, 2134 Ferreira, A 892, 894 Ferrero, A 206 Ferretti, S 855 Ferri, C 688, 689, 1201, 1454, 1529 Ferriani, VP 304 Ferriani, VP 2012 Ferro, F 471, 1933 Ferrone, C 1473 Ferrua, S 1051 Fert, I 1701 Fertig, N 229 Fervenza, F 792, 2432 Fesler, P 2528 Fessatou, S 306 Fessler, BJ 591, 592, 789, 792, 2432 Feudtner, C 2043 Feydy, A 268, 690 Fichtner, A 1248 Fidelholtz, J 1095 Field, RE 1060 Field, R 1564 Fielder, P 837 Fields, K 1716 Fields, TR 1579 Fierlbeck, G 532 Figueiredo, C 812, 899 Fiirgaard, B 299 Fike, A 1574 Filer, A 366, 374 Filipow, PL 2633 Filippini, D 2390 Filippini, M 1535 Filková, M 42, 53, 2519 Filley, C 1390, 2308 Filocamo, G 283 Filopoulos, M 2396 Filopoulos, MT 314, 2233, 2461 Finckh, A 126, 1081, 2072, 2114, 2637 Fine, JS 1148 Fine, MJ 2485 Finetti, M 273, 988, 1964, 1973, 2452 Fink, I 1943 Finkel, R 235 Finnegan, A 816, 1760 Finnegan, S 307 Finucane, C 1274 Finzel, S 807, 964, 1611, 1615, 2527 Fiocco, M 1668 Fiorentino, D 244, 668, 707, 1834, 1835 Fiori, G 1462 Fiorini, P 1578 Firestein, GS 37, 196, 385, 833, 1134, 1630, 1809, 2517 FIRST study team 1736 Fischbach, M 2029 Fischer, A 983 Fischer, A 687, 695, 1470 Fischer, HD 86 Fischer, K 1309 Fischer, MA 2441 Fischer-Betz, R 6, 582 Fisher, BA 2171 Fisher, Jr., CL 2071 Fisher, G 2348 Fisher, MC 509 Fitilev, S 2201 Fitter, S 2623 Fitz, L 834 Fitz-Gibbon, P 1188 Fitz-Patrick, D 1018 Fitzcharles, M 932, 933, 938, 1605, 1906 FitzGerald, JD 764, 788, 1025, 1037 FitzGerald, OM 520, 1176, 1203, 1352, 1559, 1722, 2422 Fitzgerald-Bocarsly, P 1428 Fitzpatrick, M 1722 Fiuza, M 2268 Flaherty, K 1714 Flannery, J 2612 Flask, CA 1789 Flatø, B 2621 Fleck, M 178, 1943 Fleckner, J 1424 Fleischmann, RM 408, 1210, 2236 Fleischmann, R 441, 1699, 2227, 2592, 2630 Fleischmann, RM 1023, 1217, 1230, 1253, 1698, 2199, 2215, 2593, 2627 Fleming, S 106 Flint, J 2225 Flipo, R 132, 438, 1641, 1932, 2234 Floerecke, M 503, 506 Flores, P 1439 Flores, R 2077 Florica, B 2267 Flynn, E 160 Flynn, JA 1297, 1298 Flynt, A 1018 Focant, I 1927 Foeldvari, I 274, 283, 2453, 2623 Foell, D 306 Foerger, F 2114 Foerster, B 970 Fogg, LF 1086 Folsom, AA 2170 Foltz, V 1068 Fonollosa, A 1044, 1045 Fonseca, C 1491 Fonseca, JE 507, 1317, 1792 Fonseca, JE 414, 444, 1934, 2242 Fontaine, KR 2124, 2132 Fontana, V 1241 Fontanillo-Fontanillo, M 2290 Fontsere, O 1042, 2062 Foo, J 194 Foocharoen, C 814, 2600 for the CARRAnet investigators 271, 278 for the Imatinib Study Group 1460 for the RAVE-ITN Research Group 2432 Forbess, LJ 700 Forde, TS 1348, 1637, 2096 Forejtova, S 408 Forslind, K 348, 436, 2229, 2513 Forslund, E 235 Forsythe, A 216, 1035, 2583 Fortin, PR 4, 22, 580, 591, 592, 661, 1375, 1383, 1398, 1667, 1708, 1880, 2064, 2267, 2269, 2273, 2275, 2292, 2303, 2368, 2639 Fortunet, C 1992 Fosang, AJ 1777 Foster, H 257 Fotheringham, I 2247 Fotopoulos, A 699 Fouche, L 1024 Foucher, KC 1086, 1990 Foulkes, W 586 Fournie, B 230 Fourret, P 791 Foussat, A 2337 Fowler, NM 1531 Fox, A 1652 Fox, DA 1756, 2334, 2572 Fox, E 750 Fox, E 391, 1829 Fox, KA 747 Fox, KM 146, 915, 1547, 2415, 2416 Fraccaroli, L 494 Fracchiolla, C 1294 Fraenkel, L 83, 107, 110, 120, 743, 756, 907, 1721, 1867, 2366, 2367 Fraga, M 2403 Fragiadaki, K 1178, 1202 Fragoso, TS 1059 2011 <strong>Program</strong> <strong>Book</strong> 351 abstract author Index
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS POLICIES Copyrigh
- Page 7 and 8:
TABLE OF CONTENTS ACR Immunology Up
- Page 9 and 10:
TABLE OF CONTENTS Vasculitis Poster
- Page 11 and 12:
However, the ACR continues to requi
- Page 13 and 14:
MEETING NAVIGATION GUIDE To navigat
- Page 15 and 16:
Newsroom Located in room W175c, use
- Page 17:
Guided Poster Tours Guided poster t
- Page 20 and 21:
FRIDAY November 4, 2011 9:15 am Ult
- Page 22 and 23:
SATURDAY, NOVEMBER 5, 2011 12:00 -
- Page 24 and 25:
SATURDAY November 5, 2011 8:35 am T
- Page 26 and 27:
SATURDAY November 5, 2011 Pain: Pat
- Page 28 and 29:
SUNDAY November 6, 2011 SUNDAY, NOV
- Page 30 and 31:
SUNDAY November 6, 2011 Upon comple
- Page 32 and 33:
EXHIBITS 10:00 am - 5:00 pm INNOVAT
- Page 34 and 35:
SUNDAY November 6, 2011 ARHP SPECIA
- Page 36 and 37:
SUNDAY November 6, 2011 W179b Rheum
- Page 38 and 39:
3:15 pm 732. Notch Signaling Pathwa
- Page 40 and 41:
SUNDAY November 6, 2011 3:15 pm 756
- Page 42 and 43:
SUNDAY November 6, 2011 Children’
- Page 44 and 45:
SUNDAY November 6, 2011 3:00 pm 791
- Page 46 and 47:
3:30 pm Demonstration and Practice
- Page 48 and 49:
Yasser M. El Miedany 1 , Maha El Ga
- Page 50 and 51:
SUNDAY November 6, 2011 48 Musculos
- Page 52 and 53:
SUNDAY November 6, 2011 5:15 pm 852
- Page 54 and 55:
SUNDAY November 6, 2011 52 4:55 pm
- Page 56 and 57:
MONDAY, NOVEMBER 7, 2011 ACR/ARHP R
- Page 58 and 59:
MONDAY November 7, 2011 W185a Scler
- Page 60 and 61:
MONDAY November 7, 2011 Upon comple
- Page 62 and 63:
Upon completion of this session, pa
- Page 64 and 65:
MONDAY November 7, 2011 W187b Basic
- Page 66 and 67:
MONDAY November 7, 2011 2:30 pm Cel
- Page 68 and 69:
MONDAY November 7, 2011 Indianapoli
- Page 70 and 71:
3:45 pm 1628. Association of Knee P
- Page 72 and 73:
MONDAY November 7, 2011 Glostrup, C
- Page 74 and 75:
MONDAY November 7, 2011 3:33 pm A R
- Page 76 and 77:
MONDAY November 7, 2011 4:30 pm Ris
- Page 78 and 79:
Institutet, Stockholm, Sweden, 6 Un
- Page 80 and 81:
5:45 pm 1700. Successful Dose De-Es
- Page 82 and 83:
MONDAY November 7, 2011 Michigan, A
- Page 84 and 85:
MONDAY November 7, 2011 4:45 pm 172
- Page 86 and 87:
MONDAY November 7, 2011 5:25 pm Imp
- Page 88 and 89:
TUESDAY November 8, 2011 ARHP CONCU
- Page 90 and 91:
TUESDAY November 8, 2011 9:25 am Is
- Page 92 and 93:
ACR PRACTICE ISSUE 9:30 - 10:30 am
- Page 94 and 95:
TUESDAY November 8, 2011 noon 2431.
- Page 96 and 97:
TUESDAY November 8, 2011 W186b Vasc
- Page 98 and 99:
ACR CLINICAL SYMPOSIA 2:30 - 4:00 p
- Page 100 and 101:
TUESDAY November 8, 2011 3:45 pm 24
- Page 102 and 103:
TUESDAY November 8, 2011 University
- Page 104 and 105:
TUESDAY November 8, 2011 and Oncolo
- Page 106 and 107:
Italy, 3 Hospital Universitario La
- Page 108 and 109:
3:10 pm Case Study Diane V. Lacaill
- Page 110 and 111:
• discuss the evidence to support
- Page 112 and 113:
TUESDAY November 8, 2011 4:45 pm 25
- Page 114 and 115:
5:15 pm 2532. Selection of Patients
- Page 116 and 117:
TUESDAY November 8, 2011 ACR/ARHP C
- Page 118 and 119:
WEDNESDAY, NOVEMBER 9, 2011 ACR/ARH
- Page 120 and 121:
9:00 am Mechanisms of Thrombosis in
- Page 122 and 123:
WEDNESDAY November 9, 2011 A. Kopec
- Page 124 and 125:
WEDNESDAY November 9, 2011 9:15 am
- Page 126 and 127:
WEDNESDAY November 9, 2011 9:45 am
- Page 128 and 129:
WEDNESDAY November 9, 2011 11:45 am
- Page 130 and 131:
WEDNESDAY November 9, 2011 Graduate
- Page 132 and 133:
11:00 am The Process: Defining Appr
- Page 134 and 135:
ACR Poster Session A 11. Myocardial
- Page 136 and 137:
ACR Poster Session A 37. Regulation
- Page 138 and 139:
ACR Poster Session A 64. Interleuki
- Page 140 and 141:
ACR Poster Session A Mexico City, M
- Page 142 and 143:
ACR Poster Session A 121. An Analys
- Page 144 and 145:
ACR Poster Session A 146. National
- Page 146 and 147:
ACR Poster Session A 165. Genome-Wi
- Page 148 and 149:
ACR Poster Session A 185. US Examin
- Page 150 and 151:
ACR Poster Session A Jones 1 , Andr
- Page 152 and 153:
ACR Poster Session A Gerald J. D. H
- Page 154 and 155:
ACR Poster Session A 258. Etanercep
- Page 156 and 157:
ACR Poster Session A GA, 6 Hospital
- Page 158 and 159:
ACR Poster Session A 305. Pathway-B
- Page 160 and 161:
ACR Poster Session A 328. Near Miss
- Page 162 and 163:
ACR Poster Session A 351. A Novel M
- Page 164 and 165:
ACR Poster Session A Sugihara 6 , K
- Page 166 and 167:
ACR Poster Session A 398. Rituximab
- Page 168 and 169:
ACR Poster Session A & Johnson Phar
- Page 170 and 171:
ACR Poster Session A 436. Predicted
- Page 172 and 173:
ACR Poster Session A Tomomi Tsuru 1
- Page 174 and 175:
ACR Poster Session A 479. Follow up
- Page 176 and 177:
ACR Poster Session A 496. A Chimeri
- Page 178 and 179:
ACR Poster Session A 518. Associati
- Page 180 and 181:
ACR Poster Session A Piestany, Slov
- Page 182 and 183:
ACR Poster Session A 576. Fn14 Defi
- Page 184 and 185:
ACR Poster Session A 593. Plasma Le
- Page 186 and 187:
ACR Poster Session A 611. Why Do Lu
- Page 188 and 189:
ACR Poster Session A 634. Associati
- Page 190 and 191:
ACR Poster Session A Alarcon-Riquel
- Page 192 and 193:
ACR Poster Session A Laboratories,
- Page 194 and 195:
ACR Poster Session A Movsisyan, Lid
- Page 196 and 197:
ACR Poster Session A Th1 Cells Expa
- Page 198 and 199:
ACR/ARHP Poster Session B College o
- Page 200 and 201:
ACR/ARHP Poster Session B 920. Econ
- Page 202 and 203:
ACR/ARHP Poster Session B Study. A.
- Page 204 and 205:
ACR/ARHP Poster Session B 974. Dise
- Page 206 and 207:
ACR/ARHP Poster Session B 1001. Mic
- Page 208 and 209:
ACR/ARHP Poster Session B 206 Khann
- Page 210 and 211:
ACR/ARHP Poster Session B 208 Pulmo
- Page 212 and 213:
ACR/ARHP Poster Session B Swearinge
- Page 214 and 215:
ACR/ARHP Poster Session B 212 Felds
- Page 216 and 217:
ACR/ARHP Poster Session B 214 Corbi
- Page 218 and 219:
ACR/ARHP Poster Session B 1161. End
- Page 220 and 221:
ACR/ARHP Poster Session B 1182. Uri
- Page 222 and 223:
ACR/ARHP Poster Session B 1205. A S
- Page 224 and 225:
ACR/ARHP Poster Session B 222 Murth
- Page 226 and 227:
ACR/ARHP Poster Session B San Diego
- Page 228 and 229:
ACR/ARHP Poster Session B 1266. Eva
- Page 230 and 231:
ACR/ARHP Poster Session B 1296. Pat
- Page 232 and 233:
ACR/ARHP Poster Session B 230 1320.
- Page 234 and 235:
ACR/ARHP Poster Session B 1348. Syn
- Page 236 and 237:
ACR/ARHP Poster Session B 1375. Ant
- Page 238 and 239:
ACR/ARHP Poster Session B 1398. Cli
- Page 240 and 241:
ACR/ARHP Poster Session B Baltimore
- Page 242 and 243:
ACR/ARHP Poster Session B 1451. Ele
- Page 244 and 245:
ACR/ARHP Poster Session B Sclerosis
- Page 246 and 247:
ACR/ARHP Poster Session B 1496. Evi
- Page 248 and 249:
ACR/ARHP Poster Session B 1518. Pro
- Page 250 and 251:
ACR/ARHP Poster Session B Hagen 1 ,
- Page 252 and 253:
ACR/ARHP Poster Session B ARHP Clin
- Page 254 and 255:
ACR/ARHP Poster Session C Karl Eger
- Page 256 and 257:
ACR/ARHP Poster Session C Tampere S
- Page 258 and 259:
ACR/ARHP Poster Session C 256 1 Jun
- Page 260 and 261:
ACR/ARHP Poster Session C Universit
- Page 262 and 263:
ACR/ARHP Poster Session C 1864. Epi
- Page 264 and 265:
ACR/ARHP Poster Session C 262 Hospi
- Page 266 and 267:
ACR/ARHP Poster Session C 2 Biogen
- Page 268 and 269:
ACR/ARHP Poster Session C 1945. Cir
- Page 270 and 271:
ACR/ARHP Poster Session C 268 1974.
- Page 272 and 273:
ACR/ARHP Poster Session C 2003. Eff
- Page 274 and 275:
ACR/ARHP Poster Session C Hosp Gast
- Page 276 and 277:
ACR/ARHP Poster Session C Toronto,
- Page 278 and 279:
ACR/ARHP Poster Session C Francisco
- Page 280 and 281:
ACR/ARHP Poster Session C 2105. Inc
- Page 282 and 283:
ACR/ARHP Poster Session C Universit
- Page 284 and 285:
ACR/ARHP Poster Session C 282 2151.
- Page 286 and 287:
ACR/ARHP Poster Session C 284 2175.
- Page 288 and 289:
ACR/ARHP Poster Session C 286 2196.
- Page 290 and 291:
ACR/ARHP Poster Session C 2217. Lon
- Page 292 and 293:
ACR/ARHP Poster Session C Research
- Page 294 and 295:
ACR/ARHP Poster Session C 2258. sIL
- Page 296 and 297:
ACR/ARHP Poster Session C 2290. The
- Page 298 and 299:
ACR/ARHP Poster Session C Universit
- Page 300 and 301:
ACR/ARHP Poster Session C 2345. IL-
- Page 302 and 303: ACR/ARHP Poster Session C 2376. Gra
- Page 304 and 305: ACR/ARHP Poster Session C 2399. Spe
- Page 306 and 307: REF Industry Roundtable-supported S
- Page 308 and 309: REF Industry Roundtable-supported S
- Page 310 and 311: Industry-supported POST-CONFERENCE
- Page 312 and 313: CERTIFICATES OF CME CREDIT OR PARTI
- Page 314 and 315: 2011 ACR/ARHP Annual Meeting Leader
- Page 316 and 317: 2011 ACR/ARHP Annual Meeting Leader
- Page 318 and 319: EXHIBITORS Abbott Pharmaceuticals B
- Page 320 and 321: EXHIBITORS Lippincott, Williams and
- Page 322 and 323: acknowledgements The ACR, the ARHP
- Page 324 and 325: Invited Speaker /Moderator Index 32
- Page 326 and 327: Invited Speaker /Moderator Index 32
- Page 328 and 329: Invited Speaker /Moderator Index Ev
- Page 330 and 331: Invited Speaker /Moderator Index 32
- Page 332 and 333: Invited Speaker /Moderator Index 33
- Page 334 and 335: Invited Speaker /Moderator Index Mu
- Page 336 and 337: Invited Speaker /Moderator Index Om
- Page 338 and 339: Invited Speaker /Moderator Index St
- Page 340 and 341: Invited Speaker /Moderator Index Wi
- Page 342 and 343: aBSTRACT author Index 340 Alpers, C
- Page 344 and 345: aBSTRACT author Index Bawa, WA 259
- Page 346 and 347: aBSTRACT author Index 344 Broder, A
- Page 348 and 349: aBSTRACT author Index 346 Chaves, L
- Page 350 and 351: aBSTRACT author Index 348 Dalbeth,
- Page 354 and 355: aBSTRACT author Index 352 Fragoso-L
- Page 356 and 357: aBSTRACT author Index Gordon, C 4,
- Page 358 and 359: aBSTRACT author Index Hemmati, I 13
- Page 360 and 361: aBSTRACT author Index 358 Ishigatsu
- Page 362 and 363: aBSTRACT author Index 360 Keeling,
- Page 364 and 365: aBSTRACT author Index 362 Kumar, V
- Page 366 and 367: aBSTRACT author Index 364 Lim, M 13
- Page 368 and 369: aBSTRACT author Index 366 Marshall,
- Page 370 and 371: aBSTRACT author Index 368 MMF/AZA L
- Page 372 and 373: aBSTRACT author Index 370 Noel, D 1
- Page 374 and 375: aBSTRACT author Index 372 Pawlita,
- Page 376 and 377: aBSTRACT author Index 374 Ramos, I
- Page 378 and 379: aBSTRACT author Index 376 Rönnblom
- Page 380 and 381: aBSTRACT author Index 378 Shaykevic
- Page 382 and 383: aBSTRACT author Index Su, J 22, 139
- Page 384 and 385: aBSTRACT author Index 382 Tomcik, M
- Page 386 and 387: aBSTRACT author Index 384 Villeneuv
- Page 388 and 389: aBSTRACT author Index 386 Wu, X 650
- Page 390 and 391: abstract keyword Index 388 18FDG PE
- Page 392 and 393: abstract keyword Index 2092, 2113,
- Page 394 and 395: abstract keyword Index 392 macropha
- Page 396 and 397: abstract keyword Index 387, 388, 38
- Page 398 and 399: Abstract Moderator disclosure A Ano
- Page 400 and 401: Abstract Moderator disclosure Jonas
- Page 402 and 403:
V van der Heijde, Desiree, MD, PhD
- Page 404 and 405:
Notes 402 2011 Program Book
- Page 406 and 407:
immunosuppressive agents is not rec
- Page 408:
In appropriate patients with psoria